News Archives | Future Medicine India


Parexel and Signify Health join hands to promote access to clinical trials

Parexel and Signify Health have announced a strategic collaboration to bring in new solutions to promote access and inclusion of more diverse and traditionally underrepresented population in clinical trials.

Read More..

Phase 3 trials for Russia’s Sputnik V vaccine to begin in India

The Drugs Controller General of India (DCGI) has given nod to conduct phase 3 clinical trial of Russia’s COVID-19 vaccine candidate, Sputnik V, in India, according to Dr. Reddy’s Laboratories.


New infections at 15K; India begins COVID-19 vaccination drive

India recorded 15,151 new COVID-19 infections on Friday. The cumulative confirmed cases have now risen to 1,05,43,659, of which 2,08,261 are active infections. The nation also recorded 16,801 recoveries and 176 deaths on the day taking the total recoveries and fatalities to 1,01,78,883 and 1,52,130 respectively.


EC approves baloxavir for treating influenza

The European Commission has approved baloxavir marboxil, sold under the brand name Xofluza, for the treatment of uncomplicated influenza in patients aged 12 years and above, announced Roche.


DuPont introduces probiotic to help reduce stress

DuPont Nutrition & Biosciences has launched Howaru Calm, a probiotic aimed at helping reduce stress. The company said that Howaru Calm’s featured strain – Lactobacillus paracasei Lpc-37, was scrupulously tested to ensure its quality, efficacy and performance.


Donanemab slows cognitive decline in Alzheimer’s, shows phase 2 data

An investigational antibody donanemab, significantly slowed reduction of cognition and daily function in early Alzheimer’s disease in the phase 2 trial, according to a press release from Eli Lilly and Company.


Equilibrium in public and private health services is need of the hour–Health Next 2021

Equilibrium in public and private health services, increased access and affordability and close looped solutions for healthcare waste are some of the most important and immediate requirements to mitigate the risks associated with COVID-19 pandemic worldwide.